Home / Health / Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Talks are also on with five major Indian manufacturers here to produce the vaccine for India and the world

Premium

The trial in India would be a bridge trial as a phase 3 trial on 40,000 volunteers is already on Russia

3 min read Last Updated : Sep 17 2020 | 1:38 AM IST

Russia's vaccine candidate, Sputnik V, which is based on human adenovirus platform, will soon be available in India if the regulator gives its approval.

Russian Direct Investment Fund (RDIF), a sovereign wealth fund, has signed a pact with Hyderabad-based Dr Reddy's Laboratories (DRL) for clinical trials and distribution of 100 million doses of Sputnik V in the country. Besides, talks are on with five major Indian manufacturers to produce the vaccine, not only for India but for the world.

Adenoviruses most commonly cause respiratory illnesses.

The cost of clinical trials would be shared equally between the two partners, DRL said on Wednesday. Shares

Topics : Coronavirus Community Transmission Dr Reddy's Coronavirus Tests Coronavirus Vaccine World Health Organization Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in